Can Ethylene Oxide Penetrate Medical Device Packaging? A Guide To EO Sterilization Compatibility

Oct 22, 2026

Medical device manufacturers must ensure that sterilization reaches the required product surfaces without compromising packaging integrity. For products sterilized with ethylene oxide (EO), packaging selection is part of the overall sterilization process rather than a separate purchasing decision.

EO is a gaseous sterilant used for compatible medical devices that may be sensitive to heat or moisture. During a validated sterilization cycle, the gas must pass through the designated permeable areas of the packaging and reach the product surfaces requiring sterilization.

Unlike a package designed solely to prevent gas transmission, an EO-compatible sterile barrier system combines controlled gas permeability with protection against microbial contamination after processing.

The EO process generally includes preconditioning, air removal, humidification, gas introduction, exposure, gas removal, and aeration. Temperature, humidity, EO concentration, and exposure time are important process variables. Packaging must withstand the conditions associated with the entire process, including pressure changes and moisture exposure.

After sterilization, residual EO must be reduced to acceptable levels through validated gas removal and aeration procedures. Packaging materials and product components can affect how readily the gas enters and leaves the packaged load.

Therefore, EO penetration depends on the permeability of the packaging system, the product configuration, and the validated process-not simply on whether the package looks porous.

Several packaging materials are commonly considered for EO-sterilized medical devices. Their suitability depends on the intended application, material grade, package construction, and sealing method.

Tyvek is a nonwoven material made from high-density polyethylene fibers. Certain medical-grade Tyvek materials are used in sterile barrier packaging because they provide a combination of microbial barrier performance, gas permeability, and mechanical strength.

Potential applications include packaging for catheters, disposable medical devices, and selected assembled instruments.

When evaluating Tyvek packaging, manufacturers should consider the specific material grade, seal compatibility, resistance to handling damage, and performance under the intended conditioning and sterilization cycle.

Tyvek should not be treated as interchangeable with every other porous packaging material. The complete packaging system must be evaluated and validated for its intended use.

Medical-grade paper is another option used in compatible EO sterilization packaging systems. Its porous structure allows gas exchange while helping maintain a microbial barrier when the paper, seals, and package design meet the applicable requirements.

Typical applications may include individually packaged disposable medical products and selected instrument packaging systems.

Important considerations include paper strength, moisture resistance, seal integrity, and the effects of conditioning and pressure changes. Paper that becomes damaged or loses structural integrity during processing may compromise the sterile barrier.

Manufacturers should select packaging materials specifically intended for the chosen sterilization method rather than assuming that ordinary paper has the required properties.

Medical sterilization pouches commonly combine a porous material, such as a suitable medical-grade paper or Tyvek, with a transparent polymer film.

The porous side permits sterilant transfer, while the polymer film provides product visibility and contributes to the package structure. The sealed pouch must maintain its integrity throughout sterilization, handling, storage, and distribution.

Pouch compatibility depends on the materials used, sealing conditions, product weight, package dimensions, and the selected EO cycle.

For products with sharp edges or rigid components, manufacturers should also assess the risk of puncturing or damaging the packaging during handling.

Some medical devices use trays, lids, protective films, cartons, or multilayer packaging assemblies. These components may perform different functions within the overall packaging system.

For example, a rigid plastic tray may protect the product, while a gas-permeable lid or porous barrier provides the designated sterilant pathway.

The suitability of such a system depends on its complete design. Engineers should identify which components permit gas transfer, which components act as barriers, and whether the finished package maintains the required sterile barrier after processing.

Not every material that is physically strong or chemically stable is suitable as a direct EO penetration pathway.

A continuous, nonporous plastic film may restrict EO transmission and prevent the required gas exchange when used as the sole barrier around a product.

However, solid plastic films are widely used as components of multilayer medical packaging. Their presence does not automatically make the entire package incompatible with EO sterilization.

The critical question is whether the completed package provides an appropriate sterilant pathway and maintains its integrity throughout the validated process.

Aluminum foil provides a strong barrier to gases and moisture. Consequently, an unperforated foil layer generally cannot serve as the direct pathway through which EO must reach a packaged product.

Nevertheless, barrier films may be used in certain packaging structures for protection during storage or distribution. Their suitability depends on how the complete package is designed and how the product is exposed to the sterilization process.

Manufacturers should distinguish between materials that block gas transmission and packaging systems that include a separate, validated permeable area.

Plastic materials do not all respond identically to sterilization. Polyethylene, polypropylene, PETG, and other polymers differ in their mechanical properties, thermal behavior, chemical resistance, and suitability for particular packaging designs.

EO may be compatible with many polymer-based products, but the compatibility of a packaging resin does not automatically establish the suitability of the finished package.

Engineers should assess dimensional stability, clarity where relevant, seal performance, mechanical strength, and changes caused by the complete sterilization cycle.

Liquids are generally not suitable for routine EO sterilization processes designed for packaged solid medical devices. Product forms that contain liquids require a separate assessment of the intended sterilization method and process design.

Dense powder products and tightly packed loads also require special evaluation because their structure may restrict gas movement or create challenging sterilization conditions.

Rather than classifying all powders or dense materials as incompatible, manufacturers should assess the actual product form, gas-access pathways, packaging, and validation requirements.

Choosing an appropriate packaging material is only one part of EO sterilization planning. Several engineering factors influence the outcome.

Gas permeability: The designated packaging pathway must allow sufficient EO transfer to the surfaces requiring sterilization. The complete system should be assessed under the intended process conditions.

Seal integrity: Seals must remain intact throughout conditioning, evacuation, gas exposure, and subsequent handling. A damaged seal can compromise the sterile barrier.

Pressure resistance: Vacuum and pressure changes can affect flexible packaging, rigid trays, and sealed containers. The cycle must be compatible with the pressure tolerance of the packaged product.

Moisture and temperature resistance: Preconditioning and humidification introduce environmental conditions that may affect paper strength, adhesives, films, and packaging seals.

Product arrangement: Package orientation, carton density, and the spacing between items influence the loading configuration. A package that performs well individually may behave differently within a dense production load.

Aeration and residual removal: EO absorbed by certain materials may require additional time to dissipate. Product materials, packaging construction, and the intended use influence the aeration process and residual assessment.

For manufacturers, these factors should be reviewed together during packaging development and sterilization validation.

EO offers several benefits for suitable medical devices and packaging systems.

Low-temperature processing: EO can be used for selected medical products that cannot tolerate the temperatures associated with conventional steam sterilization.

Penetration through compatible packaging: Properly designed porous packaging allows the sterilant to reach the required product surfaces without opening the sterile barrier.

Suitability for complex products: EO may be appropriate for selected catheters, tubing assemblies, and products with difficult-to-access surfaces, provided the process is validated.

Support for final-package sterilization: Compatible products can be sterilized in their final packaging, reducing the need to handle the product after the validated packaging and sterilization stages.

Adaptable process configuration: Temperature, humidity, vacuum, gas concentration, exposure time, and aeration requirements can be established within validated operating conditions for the intended product and load.

These benefits must be balanced against EO toxicity, flammability, occupational safety requirements, processing time, and the need to control residual chemicals.

Riches Engineering Co., LTD provides engineering solutions for ethylene oxide sterilization equipment. For manufacturers processing packaged medical devices, equipment selection should account for product dimensions, packaging characteristics, batch quantity, facility layout, and the intended sterilization workflow.

Riches supports project planning through customized equipment design, three-dimensional design before manufacturing, installation, and commissioning according to the agreed project scope.

For a packaging-sensitive sterilization project, the initial technical review should consider:

Chamber dimensions and the intended product load.

Packaging types and the number of packaged units per batch.

Product and packaging tolerance to temperature, humidity, and pressure changes.

Process control requirements for vacuum, humidification, EO exposure, and gas removal.

Aeration arrangements and the handling of residual EO.

Facility ventilation, leak detection, exhaust treatment, and other applicable safety controls.

Three-dimensional design allows customers to review equipment placement and installation space before fabrication. This is particularly useful when the sterilization system must fit an existing production facility or connect with a defined material-handling workflow.

Riches can also incorporate installation, commissioning, and IQ/OQ/PQ-related qualification support into project planning, as agreed with the customer. Equipment qualification and product-specific sterilization validation remain distinct activities and should be managed within the manufacturer's quality system.

Customers preparing an EO sterilization project should provide product drawings or dimensions, packaging specifications, batch requirements, and relevant process information. These details help establish the equipment requirements and identify packaging-related issues that need further evaluation.

Contact Riches to discuss customized EO sterilization equipment for your medical device packaging and production requirements.

Yes, provided the packaging system permits sufficient sterilant transfer and the complete process has been validated for the product and load. Not every sealed package is permeable to EO.

Certain medical-grade Tyvek materials, medical-grade papers, and compatible sterilization pouches are commonly used. The specific material and finished package must be evaluated for permeability, microbial barrier performance, seal integrity, and process resistance.

Solid plastic film may be used as one component of a multilayer package, but a nonporous film generally cannot serve as the sole direct pathway for EO penetration. The overall packaging design determines suitability.

Unperforated aluminum foil acts as a gas barrier and generally does not permit the required EO transmission through the foil itself. A packaging system using foil would need an appropriately designed sterilant pathway if EO sterilization is intended.

Validation helps demonstrate that the packaging and sterilization process can achieve the required outcome while maintaining package integrity. It also supports consistent processing and the preservation of the sterile barrier during subsequent storage and distribution.

EO sterilization depends on more than the sterilant itself. Packaging permeability, material compatibility, seal integrity, product geometry, pressure tolerance, and aeration requirements all influence whether a packaged medical device can be processed successfully.

Medical-grade Tyvek, suitable medical-grade paper, and compatible sterilization pouches are common options for EO applications. Solid plastic films and aluminum foil can serve as barrier components in certain packaging designs, but they should not be assumed to provide a direct gas pathway.

For medical device manufacturers, packaging and equipment requirements should be evaluated together before production begins. Riches supports customized EO sterilization equipment projects through engineering design, 3D layout review, installation, and commissioning according to project needs.

No Information

EO Sterilization For Plastic Medical Devices And Catheters